fasudil has been researched along with Acute Hypercapnic Respiratory Failure in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fasudil was injected peritoneally into the neonate, and the ductus was studied 30 min after injection and 60 min after birth." | 1.35 | In vivo dilatation of the ductus arteriosus by Rho kinase inhibition in the rat. ( Momma, K; Nakanishi, T; Sun, F; Toyoshima, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Momma, K | 1 |
| Toyoshima, K | 1 |
| Sun, F | 1 |
| Nakanishi, T | 1 |
1 other study available for fasudil and Acute Hypercapnic Respiratory Failure
| Article | Year |
|---|---|
In vivo dilatation of the ductus arteriosus by Rho kinase inhibition in the rat.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Animals, Newborn; Cardiovascular Surgical Pr | 2009 |